Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology

Vall Hebron Institut de Recerca

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology

Vall Hebron Institut de Recerca

Related news

VHIR team participating in the development of the treatment

Vall d'Hebron will develop a new topical treatment against discoid lupus erythematosus

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

Cardiovascular risk, key factors in lupus progression and brain fog at the lupus day

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

UCB acquires IMIDomics' patient insights business powered by VHIR's IMID Biobank

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).